Navigation Links
First Is Viewed as Best When Making Quick Decisions
Date:7/9/2012

MONDAY, July 9 (HealthDay News) -- When making quick decisions, people tend to prefer the option presented to them first, a new study shows.

Researchers from the Haas School of Business at the University of California, Berkeley, found that this idea applied to everything from choosing items on a menu to selecting a college to deciding which candidate to hire for a job. They argued that their findings could have many practical applications, including how products are marketed to consumers.

"The order of individuals performing on talent shows like American Idol, the order of potential companies recommended by a stockbroker, the order of college acceptance letters received by an applicantall of these firsts have privileged status," study co-author Dana Carney, assistant professor of management, said in a university news release. "Our research shows that managers in management or marketing, for example, may want to develop their business strategies knowing that first encounters are preferable to their clients or consumers."

In the first experiment, more than 120 participants were asked to evaluate three groups: two teams, two male salespeople and two female salespeople. Participants were introduced to the two teams one after the other. Immediately after they were introduced, the participants had to choose which group to join.

Participants were then told they were buying a car and were introduced to two salespeople, one after the other. When asked from which person they would rather buy the car, the participants always preferred the first person to whom they were introduced.

In testing their theory on preferences for consumer products, the researchers asked more than 200 passengers at a train station to choose quickly between two similar pieces of bubble gum. Once again, when forced to decide immediately, the participants mostly chose the gum that was presented to them first.

To test the "first is best" theory on more negative decisions, the researchers asked another 31 participants to view similar mug shots of two 29-year-old criminals known to have committed the same violent crimes. After seeing the photos, they were asked to decide who should get parole. Again, when "thinking fast," the participants judged the first criminal presented as more worthy of parole.

The researchers explained that in situations where people must make decisions quickly, their preferences are unconsciously and immediately guided to the options they were given first. Although there are sometimes rational reasons for wanting what they see first, the study found firsts are preferred even without good reason, which may be an evolutionary adaptation.

The study was published online July 9 in the journal PLoS ONE.

More information

The U.S. National Institute of Neurological Disorders and Stroke provides more information on how the brain works.

-- Mary Elizabeth Dallas

SOURCE: University of California, Berkeley, Haas School of Business, news release, July 2, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. First targeted nanomedicine to enter human clinical studies
2. First contact: Early intervention key in diagnosis and treatment of serious mental illness
3. Donor Kidney Re-Used in Second Patient After Failing in First
4. Many Who First Misuse Prescription Pills Get Them From Friends, Family: Report
5. First-of-its-kind Menopause Map helps women navigate treatment
6. First recipients of AcademyHealths Presidential Scholarship announced
7. Kessler Foundation researchers present at first International Congress on Cognition in MS
8. Whos the Dad? First-Trimester Blood Test May Tell
9. AGA releases first independently developed ABIM-approved Practice Improvement Module in GI
10. Dr. Yael Mosse will receive first Nachman Award in Pediatric Oncology at national conference
11. First study investigating possible link between sunscreen ingredient and endometriosis
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
First Is Viewed as Best When Making Quick Decisions
(Date:4/21/2017)... Palm Beach, FL (PRWEB) , ... April 21, 2017 , ... The staff at Palm ... , will be taking part in the 2017 London Marathon. Set to take place on ... of charitable organizations. This year, Dr. Schwartz will run as part of team EMPOWER, raising ...
(Date:4/21/2017)... ... April 21, 2017 , ... Evoke Therapy Programs , ... kicked off its 4th annual Forum for Innovative Treatment Solutions (FITS), which runs ... Therapy for Mental Health and Addiction.” , FITS’ 2017 keynote presenters will ...
(Date:4/21/2017)... ... April 21, 2017 , ... Dudnyk has announced the launch of its new ... the full potential of specialty and orphan brands can only be achieved when the ... “The Unifying Effect is at the heart of a true partnership between our agency ...
(Date:4/21/2017)... ... 2017 , ... The VIA Agency , a full-service ... Theravent, Inc. , the makers of a revolutionary new device clinically proven to ... working to expand distribution in anticipation of a national launch. VIA will be ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... campaign, AWARE: A Week of Addiction and Recovery Education, from April 24 to ... and preventing substance use disorders. , The mission of AWARE is to ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  Cogentix Medical, Inc. (NASDAQ: CGNT), a global ... Uro/Gyn and Gynecology markets with innovative and proprietary ... the Company as Senior Vice President, Marketing & ... Keswani will report directly to Darin Hammers ... is delighted that Ash has joined the Cogentix ...
(Date:4/20/2017)... Mass. , April 20, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... data from the Company,s consumer product development program, ... at the Society for Investigative Dermatology (SID) 76 ... to advance and promote the sciences relevant to ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
Breaking Medicine Technology: